secwatch.observer — SEC 8-K summary
======================================

Issuer:     PLUS THERAPEUTICS, INC. (PSTV)
CIK:        0001095981
Form:       8-K
Filed at:   2024-03-13T23:59:59+00:00
Accession:  0001193125-24-066407
Event type: other_material
Sentiment:  neutral
Materiality: 0.20
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Plus Therapeutics CEO presents at JonesResearch webcast; no material new details in filing
--------------------------------------------------------------------------------

- CEO Marc Hedrick presented at a JonesResearch webcast on March 12, 2024.
- Presentation slides filed as Exhibit 99.1 but no specific financial or operational data extracted from filing text.
- Slides to be used in upcoming investor meetings as part of Regulation FD disclosure.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1095981/000119312524066407/0001193125-24-066407-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1095981/000119312524066407/d804804d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-066407

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer